SC 13G Filing

Company

Vir Biotechnology, Inc.

Filed

December 5, 2019

Accession Number

0000898432-19-001340

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →